Meeting
2023 ASCO Annual Meeting
Role of immunotherapy in stage IV non-small cell lung cancer with liver metastasis: A NCDB analysis.
Authors
Takefumi Komiya
Penn State Cancer Institute, Hershey, PA
Takefumi Komiya , Shinkichi Takamori
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9046)
DOI
10.1200/JCO.2023.41.16_suppl.9046
Abstract #
9046
Poster Bd #
34
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Analysis of overall survival (OS) and progression-free survival (PFS) in the phase 1b clinical trial of anti–PD-1 ab (toripalimab) plus intrahepatic injection of OrienX010 in stage IV melanoma with liver metastases.
First Author: Chuanliang Cui
Poster
2023 ASCO Annual Meeting
Role of cytoreductive nephrectomy (CN) in metastatic clear cell renal cell carcinoma (mccRCC) in the era of immunotherapy (IO): An analysis of the National Cancer Database (NCDB).
First Author: Maroun Bou Zerdan
Poster
2022 ASCO Annual Meeting
Clinical outcome and potential benefits of post-progression immunotherapy for patients with metastatic NSCLC with primary resistance to ipilumumab and nivolumab in the LONESTAR phase III study.
First Author: Mehmet Altan
Poster
2021 ASCO Quality Care Symposium
Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults.
First Author: Bonnie Leung